Otsuka Progresses Digital Push With US Approval Of MDD App

First Such Adjunctive Therapy

The global first approval for the digital adjunctive therapeutic for MDD can further expand Otsuka's digital portfolio.
global-first approval for digital adjunct therapy for MDD set to expand Otsuka's digital health portfolio • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip